SyntheticGestalt

SyntheticGestalt is a UK-based startup with the slogan "Scientific Research by Artificially Intelligent Agents." Founded in 2018, the company operates in the Information Technology, Pharmaceutical, and Machine Learning industries. Their primary focus is on developing machine learning models for drug discovery and creating software to facilitate and automate research in the life-sciences industry. Notably, the company recently secured a $11.00M Series A investment on 29 September 2021. The investment was led by Incubate Fund, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), Headline Asia (formerly Infinity Ventures), and The Future Fund, showcasing substantial investor interest in their innovative approach.